Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline to present new drug data at ERS 2016

GlaxoSmithKline to present new drug data at ERS 2016

31st August 2016

GlaxoSmithKline has announced that it will be sharing new research data at this week's European Respiratory Society (ERS) International Congress.

The company will present more than 30 abstracts at the meeting, which will be held in London from September 3rd to 7th, including data from FULFIL, a phase III study assessing a new triple combination therapy for the treatment of chronic obstructive pulmonary disease (COPD).

Results from the Salford Lung Study in COPD will also be shared, showing the effectiveness and safety of Relvar Ellipta compared to patients' usual care, as well as findings from Vestri, a long-term safety study for Advair Diskus among children with asthma.

Finally, insights into the burden of severe asthma and the role of the anti-IL 5 monoclonal antibody Nucala in treating severe refractory eosinophilic asthma will be discussed.

Professor Neil Barnes, global respiratory franchise medical head at GlaxoSmithKline, said: "As the largest respiratory scientific meeting in the world, the ERS provides a great forum to share and debate the ongoing research we are conducting to advance respiratory science and help patients with lung disease."

The company has been recognised as a leader in the respiratory disease field for more than 45 years.

With? ?over? ?20? ?years? ?of? ?experience? ?within? ?the? ?pharmaceutical? ?market,? ?we? ?at? ?Zenopa? ?have? ?the knowledge,? ?skills? ?and? ?expertise? ?to? ?help? ?find? ?the? ?right? ?job? ?for? ?you.? ?To? ?find? ?out? ?more? ?about? ?the current? ?pharmaceutical? ?roles? ?we? ?have? ?available,? ?you? ?can? ?search? ?for? ?the? ?latest? ?job? ?roles, register? ?your? ?details,? ?or? ?contact? ?the? ?team? ?today.ADNFCR-8000103-ID-801824511-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.